CLINICAL_TRIALS ClinicalTrials.gov record update

SIPO1-AD: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Siponimod in Patients With Mild Alzheimer's Disease

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06639282
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:28:18.425044+00:00
Published At: 2026-03-04T00:00:00+00:00
Record Updated At: 2026-03-04
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Alzheimer Disease", "Mild Alzheimer Disease", "MCI With Increased Risk for Alzheimer Disease", "Cognitive Impairment, Mild"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-03-04"
protocolSection.identificationModule.nctId: "NCT06639282"
protocolSection.identificationModule.officialTitle: "SIPO1-AD: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Siponimod in Patients With Mild Alzheimer\u0027s Disease"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.